✦ LIBER ✦

Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients

✍ Scribed by Michele Molinari; Kenneth Berman; Glenda Meeberg; James A. Shapiro; David Bigam; James F. Trotter; Norman Kneteman

Book ID: 110917314
Publisher: Springer
Year: 2010
Tongue: English
Weight: 366 KB
Volume: 23
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2009.00969.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of everolimus-based immunos

Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients

✍ Mélanie Vallin; Olivier Guillaud; Isabelle Morard; Marie-Claude Gagnieu; Gilles 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Sirolimus-based immunosuppression in liv

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis

✍ Wenhua Liang; Dongping Wang; Xiaoting Ling; Andrew Allen Kao; Yuan Kong; Yushu S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

Sirolimus (SRL) is a novel immunosuppressant with antitumor properties. We performed a meta-analysis to determine whether SRL can improve patient survival and decrease the risks of tumor recurrence in patients with a pretransplant diagnosis of hepatocellular carcinoma (HCC). We searched databases fo

Sirolimus addition to tacrolimus-based i

Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient

✍ Katharina Staufer; Martina Sterneck; Hansjoerg Schaefer; Bjoern Nashan; Lutz Fis 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 210 KB

Safe conversion of mycophenolate mofetil

Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression

✍ AMGAD E EL-AGROUDY; KHALED F EL-DAHSHAN; EHAB W WAFA; HUSSIEN A SHEASHAA; ZIAD A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

A comparison of sirolimus vs. calcineuri

A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation

✍ H. ZAGHLA; R. R. SELBY; L. S. CHAN; J. A. KAHN; J. A. DONOVAN; N. JABBOUR; Y. GE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Low incidence of cytomegalovirus disease

Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper

✍ J.F. Trotter; A. Wallack; T. Steinberg 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB